Due to characteristics such as large tumor mutation load, high expression of programmed cell death-Ligand 1(PD-L1), and high proportion of tumor-infiltrating lymphocytes, immunotherapy might be effective in patients with TNBC [13, 14]. The gene discussed is CD274; the disease is neoplasm.